Prospective comparison of outcomes with azacitidine and decitabine in patients with AML ineligible for intensive chemotherapy.
Amer M ZeidanPierre FenauxMarco GobbiJiří MayerGail J RobozJürgen KrauterTadeusz RobakHagop M KantarjianJan NovákWieslaw Wiktor JedrzejczakXavier ThomasMario Ojeda-UribeYasushi MiyazakiYoo Hong MinSu-Peng YehJoseph M BrandweinLiana GerchevaJudit DemeterElizabeth A GriffithsKaren W L YeeJean-Pierre J IssaJan Philipp BewersdorfHarold KeerYong HaoMohammad AzabHartmut DöhnerPublished in: Blood (2022)